Evotec Results Presentation Deck

in € m evotec 231.0 222.4 -8.6 M Portfolio¹) Revenue H1 Organic growth 2020 excl. portfolio¹) Revenues H1 2020 PAGE 12 Growth acceleration continues in second quarter Revenue bridge H1 2020 - H1 2021 - Evotec SE and subsidiaries ¹) Sanofi payment Q1 2020 -11.5 60.4 fx effect 271.3 Revenues H1 2021 • 17% growth of Group revenues • fx effect: € (11.5) m (-5%) Organic growth of € 60.4 m translates in record growth rate of 27%, driven by base business and in particular strong demand for EVOIR&D offering ● Organic growth reached 28% in Q2 after 26% in Q1

View entire presentation